Annual report pursuant to Section 13 and 15(d)

Balance Sheet

v3.21.1
Balance Sheet
Dec. 31, 2020
USD ($)
ASSETS  
Current asset - cash $ 35,614
Deferred offering costs 469,160
TOTAL ASSETS 504,774
Current liabilities  
Accrued expenses 330,300
Promissory note - related party 150,000
Total current liabilities 480,300
Commitments and Contingencies
Stockholder’s Equity  
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; no shares issued and outstanding 0
Common stock, $0.0001 par value; 50,000,000 shares authorized; 6,900,000 shares issued and outstanding 690 [1]
Additional paid-in capital 24,310
Accumulated deficit (526)
Total Stockholder’s Equity 24,474
TOTAL LIABILITIES AND STOCKHOLDER’S EQUITY $ 504,774
[1] Includes up to 900,000 shares subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters (see Note 5). On January 11, 2021, the Company effected a stock dividend of 1,150,000 shares with respect to the common stock, resulting in an aggregate of 6,900,000 shares of common stock issued and outstanding. All shares and associated amounts have been retroactively restated to reflect the share dividend (see Note 5 and 8). On January 19, 2021, the underwriters exercise the over-allotment option in full. As a result, the 900,000 shares are no longer subject to forfeiture.